Colorectal Cancer
Cancer of the colon or rectum — among the most common cancers worldwide and a major focus of screening and drug development.
Coverage of Colorectal Cancer is holding steady : 147 signals on the latest tracked day, up 101% from its three-week baseline of 73, across 3 domains (unchanged from a week ago). That makes it the #1 most-covered of the 289 concerns we track.
What’s changed
- Quercetin as the core constituent of Huanglian decoction: Targeting AKT1 for colorectal cancer therapy. · Pak J Pharm Sci · 2026-10-01
- [Efficacy and safety of different sizes drug eluting beads in the treatment of colorectal cancer liver metastasis by TACE]. · Zhonghua Zhong Liu Za Zhi · 2026-08-23
- The past, present, and future treatment of BRAFV600-mutant metastatic colorectal cancer: A comprehensive review. · Cancer · 2026-08-15
- The Role of Circulating Tumor Cell Dynamics in the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis. · Crit Rev Oncol Hematol · 2026-08-15
- Study links body mass and prediagnosis weight loss to colorectal cancer survival - Bioengineer.org · Colorectal Cancer Treatment (Google News) · 2026-08-15 · usually covers CRC Treatment
- Monocyte-derived IL-1β/p65/KRT7/ILK pathway drives epithelial–mesenchymal transition in colorectal cancer - Bioengineer.org · CRC Research (Google News) · 2026-08-15 · usually covers Gi Journal
What the reporting says
It shows up alongside Immunotherapy (195), ctDNA (96), KRAS (94), MSI-H (53), Braf (47), Wang (55), Zhang (49), Chen (43).
Two steps out: G12d (through KRAS, 57 shared stories on the weaker link); Pancreatic Cancer (through KRAS, 49 shared stories on the weaker link); FDA (through Immunotherapy, 32 shared stories on the weaker link); Abstract (through Immunotherapy, 29 shared stories on the weaker link).
Tracked since Jul 21, with coverage on 158 separate days — concentrated in Pubmed Targeted and Oncology.